Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $224K invested in Sonnet BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$1.82K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MI
1
MMCAP International
Grand Cayman,
Cayman Islands
| $166K | 133,590 | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $30.9K | 24,892 | +87 | +0.4% |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $16.9K | 13,668 | +13,668 | New |
|
4
UBS Group
Zurich,
Switzerland
| $8.26K | 6,659 | +6,518 | +4,623% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1.82K | 1,465 | -1,122 | -43% |
|
6
BlackRock
New York
| $81 | 65 | – | – |
|
|
CWA
7
Carolina Wealth Advisors
Myrtle Beach,
South Carolina
| $40 | 32 | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $36 | 29 | +3 | +12% |
|
9
Raymond James Financial
St Petersburg,
Florida
| $7 | 6 | +6 | New |
|
10
Barclays
London,
United Kingdom
| – | – | -17 | Closed |
|